| CAS编号 | 中文名 | 英文名 | 分子式 | 分子量 | 熔点 | 沸点 |
| 103839-22-1 | | 13,18-dehydro-6alpha-senecioyloxychaparrin | | | | |
| 1038392-13-0 | | (1-(tetrahydro-2h-pyran-2-yl)-1h-pyrazol-4-yl)methanol | C9H14N2O2 | 182.22 | | |
| 1038392-15-2 | (1-(四氢-2H-吡喃-2-基)-1H-吡唑-4-基)甲胺 | (1-(Tetrahydro-2H-pyran-2-yl)-1H-pyrazol-4-yl)methanamine | C9H15N3O | 181.2300 | | |
| 1038392-63-0 | 5-溴-2-甲基-1H-苯并[d]咪唑-1-甲酸叔丁酯 | tert-Butyl 5-bromo-2-methyl-1H-benzo[d]imidazole-1-carboxylate | C13H15BrN2O2 | 311.17 | | |
| 1038393-19-9 | 8-溴咪唑并[1,2-a]吡啶-2-羧酸乙酯 | ethyl 8-bromoimidazo[1,2-a]pyridine-2-carboxylate | C10H9BrN2O2 | 269.09 | | |
| 1038393-47-3 | (R)-1-(4-(甲基磺酰基)苯基)乙胺 | (R)-1-(4-(methylsulfonyl)phenyl)ethanamine | | | | |
| 1038393-51-9 | | (R)-2-amino-3-cyclopropylpropan-1-ol hcl | | | | |
| 1038393-52-0 | | (S)-2-amino-3-cyclopropylpropan-1-ol hcl | | | | |
| 1038395-63-9 | 2-(5-(4-(2-morpholinoethoxy)phenyl)pyridin-2-yl)acetonitrile | | C19H21N3O2 | 323.39 | | |
| 1038395-64-0 | 2-(5-(4-(2-吗啉基乙氧基)苯基)吡啶-2-基)乙酸甲酯 | Methyl 2-(5-(4-(2-morpholinoethoxy)phenyl)pyridin-2-yl)acetate | C20H24N2O4 | 356.42 | | |
| 1038395-65-1 | | kx2-391 dihydrochloride | C26H31Cl2N3O3 | 504.45 | | |
| 1038398-68-3 | | 5-[4-(trifluoromethyl)phenyl]-1h-pyrazole-3-carboxylic acid | C11H7F3N2O2 | 256.18 | | |
| 103840-23-9 | | phenol, 4-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethoxy)-2-methyl-5-(1-methyleth | | | | |
| 103840-25-1 | | 2-methyl-5-(1-methylethyl)-4-(2-(4-phenyl-1-piperazinyl)ethoxy)-pheno monoh | | | | |
| 103840-27-3 | | phenol, 2-methyl-5-(1-methylethyl)-4-(2-(4-(3-(trifluoromethyl)phenyl)-1-pipera | | | | |
| 103840-29-5 | | phenol, 4-(2-(4-(4-fluorophenyl)-1-piperazinyl)ethoxy)-2-methyl-5-(1-methylethy | | | | |
| 103840-32-0 | | phenol, 2-methyl-5-(1-methylethyl)-4-(2-(4-(2-methylphenyl)-1-piperazinyl)ethox | | | | |
| 103840-36-4 | | phenol, 2-methyl-5-(1-methylethyl)-4-(2-(methyl(2-(4-phenyl-1-piperazinyl)ethyl | | | | |
| 103840-38-6 | | phenol, 4-(2-(4-(4-methoxyphenyl)-1-piperazinyl)ethoxy)-2-methyl-5-(1-methyleth | | | | |
| 103840-40-0 | | phenol, 4-(2-(4-(2,3-dimethylphenyl)-1-piperazinyl)ethoxy)-2-methyl-5-(1-methyl | | | | |
| 103840-42-2 | | phenol, 4-(2-(4-(2-chlorophenyl)-1-piperazinyl)ethoxy)-2-methyl-5-(1-methylethy | | | | |
| 103840-44-4 | | phenol, 4-(2-(4-(2-ethoxyphenyl)-1-piperazinyl)ethoxy)-2-methyl-5-(1-methylethy | | | | |
| 103840-52-4 | | 1-(cyclopropylmethyl)-4-(2-pyridinyl)-piperazin ethanedioate (1:1) | | | | |
| 103840-55-7 | | 1-(cyclobutylmethyl)-4-(2-pyridinyl)-piperazin ethanedioate (2:3) | | | | |
| 103840-57-9 | | 1-(cyclohexylmethyl)-4-(2-pyridinyl)-piperazin ethanedioate (1:2) | | | | |
| 103840-59-1 | | n,n-bis(1-methylethyl)-4-(2-pyridinyl)-1-piperazineethanamin ethanedioate ( | | | | |
| 103840-61-5 | | hexahydro-1-(2-(4-(2-pyridinyl)-1-piperazinyl)ethyl)-1h-azepin ethanedioate | | | | |
| 103840-63-7 | | n,n-diethyl-4-(2-pyridinyl)-1-piperazinepropanamin ethanedioate (1:3) | | | | |
| 103840-65-9 | | 1-(2-pyridinyl)-4-(3-(1-pyrrolidinyl)propyl)-piperazin ethanedioate (1:3) | | | | |
| 103840-67-1 | | hexahydro-1-(3-(4-(2-pyridinyl)-1-piperazinyl)propyl)-1h-azepin ethanedioat | | | | |
| 103840-71-7 | | 2,6-dimethyl-4-(3-(4-(2-pyridinyl)-1-piperazinyl)propyl)-morpholin ethanedi | | | | |
| 103840-75-1 | | n-(3-fluorophenyl)-4-(2-pyridinyl)-1-piperazineacetamid ethanedioate (1:1) | | | | |
| 103840-79-5 | | 4-(2-pyridinyl)-n-(3-(trifluoromethyl)phenyl)-1-piperazineacetamid ethanedi | | | | |
| 103840-81-9 | | 1-(2-pyridinyl)-4-((3,4,5-trimethoxyphenyl)methyl)-piperazin ethanedioate ( | | | | |
| 1038408-35-3 | 5-溴-n1-异丙基-1,2-苯二胺 | 5-bromo-n1-isopropyl-1,2-benzenediamine | C9H13BrN2 | 229.12 | | |
| 1038408-36-4 | 6-溴-1-异丙基-2-甲基-1h-苯并咪唑 | 6-bromo-1-isopropyl-2-methyl-1h-benzimidazole | C11H13BrN2 | 253.14 | | |
| 1038408-75-1 | | 1-(4-(methylsulfonyl)phenyl)-1h-pyrazole-4-carbaldehyde | | | | |
| 1038409-55-0 | | tert-butyl 4-[3-(methoxycarbonyl)benzamido]piperidine-1-carboxylate | | | | |
| 1038409-56-1 | | 3-[1-(tert-butoxycarbonyl)piperidin-4-ylcarbamoyl]benzoic acid | | | | |
| 1038410-49-9 | (间甲苯磺酰基)-l-脯氨酸 | (m-tolylsulfonyl)-l-proline | | | | |
| 103842-36-0 | | gastric inhibitory polypeptide (1-39 | | | | |
| 103842-51-9 | | iv(3)-neuac-lcose4cer | | | | |
| 103842-84-8 | | isoflavonoid 1461 | | | | |
| 103844-77-5 | | necopidem | | | | |
| 103844-86-6 | | saripidem | | | | |
| 103845-98-3 | | 8-bromo-2,3-dihydro-5h-as-triazino(5,6-b)indole-3-thione | | | | |
| 1038478-70-4 | | ethyl 3-oxo-3,4-dihydro-2h-1,4-benzoxazine-7-carboxylate | | | | |
| 103848-61-9 | | 6-maleimidocaproic acid sulfo-nhs sodium salt | | | | |
| 103848-62-0 | 间马来酰亚胺苯甲酰基-n-羟基磺基琥珀酰亚胺酯 | sulfo-mbs (m-maleimidobenzoyl-n-hydroxysulfosuccinimide ester) | | | | |
| 103849-39-4 | | 3-benzenediol, 4-(3-((1-methyl-2-phenylethyl)amino)-1-phenylpropyl)- hydroch | | | | |
m.cnreagent.com